Nise Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 52.68%
- Profit Growth -63.12%
- Ebitda 5.31%
- Net Worth 572.89%
- Total Assets 20.73%
About Nise Pharma Chem
Nise Pharma Chem Private Limited (NPCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 January 2012 and has a history of 13 years and one month. Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kishore Guduru and Kalyani Guduru serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233MH2012PTC226109
- Company No.
226109
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nise Pharma Chem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishore Guduru  | Managing Director | 16-Jan-2012 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalyani Guduru | Director | 16-Jan-2012 | Current |
Financial Performance of Nise Pharma Chem.
Nise Pharma Chem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.68% increase. The company also saw a substantial fall in profitability, with a 63.12% decrease in profit. The company's net worth Soared by an impressive increase of 572.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nise Pharma Chem?
Unlock access to Nise Pharma Chem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nise Pharma Chem?
Unlock and access historical data on people associated with Nise Pharma Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nise Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nise Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.